Enanta Pharmaceuticals, Inc. (ENTA)
10.71
-0.44
(-3.95%)
USD |
NASDAQ |
Oct 30, 16:00
10.76
+0.06
(+0.51%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap : 311.88M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 311.88M |
| October 29, 2026 | 324.69M |
| October 28, 2026 | 336.34M |
| October 27, 2026 | 354.68M |
| October 26, 2026 | 349.44M |
| October 23, 2026 | 338.96M |
| October 22, 2026 | 338.37M |
| October 21, 2026 | 329.35M |
| October 20, 2026 | 339.83M |
| October 19, 2026 | 332.26M |
| October 16, 2026 | 323.23M |
| October 15, 2026 | 334.01M |
| October 14, 2026 | 325.56M |
| October 13, 2026 | 335.46M |
| October 12, 2026 | 358.18M |
| October 09, 2026 | 364.00M |
| October 08, 2026 | 352.35M |
| October 07, 2026 | 360.21M |
| October 06, 2026 | 354.39M |
| October 05, 2026 | 366.91M |
| October 02, 2026 | 377.40M |
| October 01, 2026 | 373.90M |
| September 30, 2026 | 383.80M |
| September 29, 2026 | 368.08M |
| September 28, 2026 | 367.35M |
| Date | Value |
|---|---|
| September 25, 2026 | 345.95M |
| September 24, 2026 | 349.44M |
| September 23, 2026 | 347.98M |
| September 22, 2026 | 361.67M |
| September 21, 2026 | 352.64M |
| September 18, 2026 | 355.26M |
| September 17, 2026 | 364.58M |
| September 16, 2026 | 369.82M |
| September 15, 2026 | 357.88M |
| September 14, 2026 | 382.05M |
| September 11, 2026 | 377.40M |
| September 10, 2026 | 369.82M |
| September 09, 2026 | 385.55M |
| September 08, 2026 | 393.12M |
| September 04, 2026 | 410.01M |
| September 03, 2026 | 408.26M |
| September 02, 2026 | 410.30M |
| September 01, 2026 | 393.41M |
| August 31, 2026 | 388.17M |
| August 28, 2026 | 396.03M |
| August 27, 2026 | 401.86M |
| August 26, 2026 | 412.05M |
| August 25, 2026 | 410.01M |
| August 24, 2026 | 410.59M |
| August 21, 2026 | 392.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 131.20M |
| Vertex Pharmaceuticals, Inc. | 141.59B |
| Coherus Oncology, Inc. | 128.23M |
| BridgeBio Pharma, Inc. | 14.64B |
| RenovoRx, Inc. | 60.01M |
Market Cap Related Metrics
| PS Ratio | 4.442 |
| Price to Book Value | 3.086 |
| Price | 10.71 |
| Earnings Yield | -22.51% |